Algernon Pharmaceuticals Inc. announces private placement of 200,000 Class A common shares at a issue price of CAD 0.085 per share for gross proceeds of CAD 17,000 on April 3, 2024. The company will issue securities pursuant to exemption provided under Regulation D. The transaction included participation from one non accredited investor.